Tahoe

Drug Discovery · South San Francisco, CA · Founded 2022 · Privately Held (backing)

Operator of a biotech company intended to combine data to find better targets and drugs that can treat patients. Tahoe is based in South San Francisco, CA and was founded in 2022. It was valued at $131 million at its early-stage round in Aug 2025, the last priced event on record. It has raised $50 million across 1 recorded round; the latest was a $35 million Series A in Aug 2025.

PMV mark · valuation
$131.0M
Oct 2026
Priced at
its early-stage round
Aug 2025
Total raised
$50.0M
Last round
Early Stage VC (Series A)
Aug 2025
What is Tahoe worth?
$131.0MPrivateMarketView mark · Oct 2026

Valued at $131.0M at its early-stage round, Aug 2025. Nothing has traded since.

Free account
More of Tahoe with a free account
  • ·The complete investor list: 12 names
  • ·Watch Tahoe: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Tahoe funding history

1 rounds
DateRoundRaisedPost-money
Aug 2025Early Stage VC (Series A)$35.0M▮
Unlock post-money valuations

Membership and data by Private Market View

Tahoe valuation

Tahoe was valued at $131 million at its early-stage round in Aug 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Tahoe raised?

Tahoe has raised $50 million in total; 1 of its rounds is on record. The largest on record was a $35 million Series A in Aug 2025.

Comparable companies

Comparable drug discovery names by valuation on PrivateMarketView: Alchemab Therapeutics ($138 million), Imbria Pharmaceuticals ($132 million) and Vivace Therapeutics ($125 million).

How Tahoe's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Tahoe, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Tahoe

What is Tahoe worth?
Tahoe is valued at $131.0M as of Oct 2026. Valued at $131.0M at its early-stage round, Aug 2025. Nothing has traded since.
How much has Tahoe raised?
Tahoe has raised $50.0M in total funding across 1 recorded rounds.
When did Tahoe last raise?
Tahoe last raised in Aug 2025 (Early Stage VC (Series A)), raising $35.0M.